Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Z Rheumatol ; 71(2): 147-50, 153-5, 2012 Feb.
Article in German | MEDLINE | ID: mdl-22370806

ABSTRACT

Patients with inflammatory rheumatic diseases are known to have an increased risk of infections due to the rheumatic disease itself and due to therapy with immunosuppressive agents. The most important procedure to prevent infections is vaccinations, which are usually well-tolerated. The German National Commission for Immunization ( STIKO) has published recommendations for patients with an immunodeficiency. The German Society of Rheumatology (DGRh) has generally implemented these recommendations for patients with chronic inflammatory rheumatic diseases. The immunization status of patients with rheumatic diseases is of increasing importance in routine patient care because some of the recently approved drugs may influence the strength of the immune response to vaccination. However, there is almost no information about the current immunization status and the willingness of patients with rheumatic diseases to undergo vaccination procedures in Germany. There are also no epidemiologic data on the implementation of recommendations for immunization at the level of general practitioners. Here we present the results of a prospective study on the efficacy of standardized recommendations for immunization given to different patient groups with rheumatic diseases treated in a hospital specialized in rheumatology.


Subject(s)
Immunization Programs , Rheumatic Diseases/immunology , Antibody Formation/drug effects , Antibody Formation/immunology , Antirheumatic Agents/adverse effects , Antirheumatic Agents/therapeutic use , Biological Products/adverse effects , Biological Products/therapeutic use , Cooperative Behavior , Female , Germany , Glucocorticoids/adverse effects , Glucocorticoids/therapeutic use , Humans , Immunization Schedule , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Interdisciplinary Communication , Male , Medical Records , Methotrexate/adverse effects , Methotrexate/therapeutic use , Middle Aged , Patient Admission , Patient Compliance , Rheumatic Diseases/drug therapy
2.
Ann Rheum Dis ; 70(10): 1782-7, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21821621

ABSTRACT

BACKGROUND: The value of clinical items defining inflammatory back pain to identify patients with axial spondyloarthritis (SpA) in primary care is unclear. OBJECTIVE: To identify predictive clinical parameters for a diagnosis of axial SpA in patients with chronic back pain presenting in primary care. METHODS: Consecutive patients aged < 45 years (n=950) with back pain for > 2 months who presented to orthopaedic surgeons (n=143) were randomised based on four key questions for referral to rheumatologists (n=36) for diagnosis. RESULTS: The rheumatologists saw 322 representative patients (mean age 36 years, 50% female, median duration of back pain 30 months). 113 patients (35%) were diagnosed as axial SpA (62% HLA B27+), 47 (15%) as ankylosing spondylitis (AS) and 66 (21%) as axial non-radiographic SpA (nrSpA). Age at onset ≤ 35 years, improvement by exercise, improvement with non-steroidal anti-inflammatory drugs, waking up in the second half of the night and alternating buttock pain were identified as most relevant for diagnosing axial SpA by multiple regression analysis. Differences between AS and nrSpA were detected. No single item was predictive, but ≥ 3 items proved useful for good sensitivity and specificity by receiver operating characteristic modelling. CONCLUSION: This study shows that a preselection in primary care of patients with back pain based on a combination of clinical items is useful to facilitate the diagnosis of axial SpA.


Subject(s)
Axis, Cervical Vertebra , Back Pain/etiology , Spondylarthritis/diagnosis , Adolescent , Adult , Age Distribution , Age of Onset , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Chronic Disease , Diagnosis, Differential , Early Diagnosis , Epidemiologic Methods , Female , HLA-B27 Antigen/analysis , Humans , Male , Patient Selection , Primary Health Care/methods , Referral and Consultation , Spondylarthritis/complications , Spondylarthritis/drug therapy , Spondylitis, Ankylosing/complications , Spondylitis, Ankylosing/diagnosis , Spondylitis, Ankylosing/drug therapy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...